Find uplifting stories about heroes, innovations, and solutions
15315 results for "weight loss breakthrough"
A breakthrough study shows the diabetes drug semaglutide helps older adults lose significant weight safely while improving heart health. Nearly half of participants over 65 achieved at least 15% weight loss in just over a year.
A new weight-loss pill from AstraZeneca helped trial participants lose nearly 12% of their body weight in just nine months, offering fresh hope in the race to make weight management easier. The tablet could soon give doctors and patients another powerful tool in fighting obesity.
New research challenges concerns that popular GLP-1 medications like Wegovy and Zepbound cause excessive muscle loss. The findings offer reassurance to millions considering or using these breakthrough weight-loss treatments.
A new obesity treatment from pharmaceutical company Boehringer has shown promising results, helping patients lose an average of 16.6% of their body weight in clinical trials. The breakthrough adds another tool to the growing arsenal of effective weight loss medications changing lives worldwide.
People using GLP-1 weight loss medications may not need weekly injections forever. A new study shows many patients maintain their weight loss while spacing out doses to every two or even six weeks.
Breakthrough weight loss medications like Ozempic could help address rising obesity rates among people living with HIV in South Africa. Early research suggests these drugs work just as well for HIV patients as everyone else.
Scientists discovered that popular diabetes and weight-loss medications might fight depression by feeding helpful gut bacteria, not by acting on the brain directly. This breakthrough could lead to probiotic treatments for people battling both obesity and depression.
Millions who avoid needles can now access a breakthrough weight loss medication in pill form. The FDA just approved oral semaglutide and a higher-dose option, making effective obesity treatment easier than ever.
Scientists are testing a breakthrough obesity treatment that helps people lose up to a third of their body weight without sacrificing muscle mass. The triple-action drug retatrutide could solve one of the biggest problems with current weight-loss medications.
NIH researchers discovered why popular GLP-1 medications like Ozempic eventually stop working as well, and they found a possible solution. The breakthrough could help millions push past frustrating weight loss plateaus.
A tiny molecule discovered using AI mimics Ozempic's weight loss effects without the nausea, constipation, or muscle loss. Animal studies show the peptide targets only the brain's appetite center, not the entire digestive system.
A promising triple-action medication could help people lose weight without sacrificing muscle. Retatrutide shows potential for safer weight loss with fewer side effects than earlier medications.
Danish researchers found that popular GLP-1 drugs like semaglutide reduced asthma flare-ups by a quarter and cut inhaler dependence by 14%. The breakthrough suggests these medications do more than just help with weight loss.
A new experimental obesity treatment targeting three hormones has shown significant weight loss in early testing. The "triple-G" drug from Kailera offers fresh hope in the rapidly expanding field of weight management medicine.
A new diabetes treatment from Eli Lilly helped patients lose 15% of their body weight while improving blood sugar control, potentially becoming the most effective weight loss diabetes drug yet. The results offer hope for millions who struggle to shed pounds while managing their condition.
%2Fhttps%3A%2F%2Ftf-cmsv2-smithsonianmag-media.s3.amazonaws.com%2Ffiler_public%2Ff8%2Ff8%2Ff8f86afc-d21d-40cc-86c9-e212d1e51222%2Fleslie_leinwand_snake_research_0181.jpg)
Scientists discovered an appetite-suppressing molecule in python blood that helped obese mice lose 9% of their body weight without the stomach problems that plague current weight-loss drugs. This breakthrough could lead to a new generation of treatments inspired by nature's most extreme fasters.
Danish scientists discovered that losing weight doesn't just shrink fat cells—it actually helps regenerate healthier fat tissue. The breakthrough research shows that even modest weight loss can reverse obesity-related inflammation and restore fat tissue to a state resembling lean, healthy individuals.
A pill-based weight loss medication achieved up to 12% body weight reduction in clinical trials, offering a more accessible alternative to injectable drugs like Ozempic. The oral drug could transform obesity treatment by eliminating needles, refrigeration, and high manufacturing costs.
Scientists discovered that two genes can help predict who will lose weight on popular obesity medications and who might experience side effects. The breakthrough could personalize treatment for millions seeking help with weight loss.
Two major clinical trials show people can maintain their weight loss by switching to lower doses or once-daily pills after initial treatment. The findings offer hope for tackling one of obesity care's biggest challenges: keeping weight off after losing it.
Showing 20 of 15315